Typicality: | 0.612 |
Saliency: | 0.472 |
on symptoms | 14 | other |
at the end of the study | 12 | temporal |
in another study | 8 | location |
subject → complete → questionnaire | 100 |
subject → complete → the questionnaire | 13 |
negative | neutral | positive |
0.110 | 0.836 | 0.054 |
Raw frequency | 113 |
Normalized frequency | 0.472 |
Modifier score | 0.995 |
Perplexity | 66.727 |